MEDICINOVA INC (MNOV) Stock Analyst Earnings Estimates
NASDAQ:MNOV - Nasdaq - US58468P2065 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.04M | -100.00% | 1M | -100.00% | 41.353M | 164.66M 298.18% | 561.72M 241.14% | 967.03M 72.16% | |||||
| EBITDA YoY % growth | -10.19M 28.04% | -14.61M -43.38% | -9.88M 32.38% | N/A -28.08% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -10.22M 27.93% | -14.63M -43.15% | -9.9M 32.33% | -12.899M -28.03% | -30.231M -138.50% | -30.702M -1.56% | -34.68M -12.96% | -24.684M 28.82% | 9.87M 139.99% | 70.152M 610.76% | 261.67M 273.00% | 455.28M 73.99% | |
| Operating Margin | -252.97% | N/A | -990.03% | N/A | N/A | N/A | N/A | N/A | 23.87% | 42.60% | 46.58% | 47.08% | |
| EPS YoY % growth | -0.20 32.66% | N/A -55.55% | -0.18 42.14% | -0.23 -27.78% | -0.41 -77.39% | -0.36 11.25% | -0.41 -12.68% | -0.45 -10.00% | -0.06 86.36% | 0.99 1,716.67% | 4.29 334.02% | 6.67 55.34% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.10 -93.80% | -0.10 -70.00% | -0.11 -87.00% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.376M -142.10% | -7.344M -121.93% | -7.344M -130.68% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.06 | -0.14 | 0.08 | 57.98% |
| Q4 2024 Q2Q % growth | -0.06 -50.00% | -0.06 | 0.00 | -6.95% |
| Q3 2024 Q2Q % growth | -0.06 -500.00% | -0.06 | 0.00 | 1.96% |
| Q2 2024 Q2Q % growth | -0.05 16.67% | -0.06 | 0.01 | 18.30% |
| Q1 2024 Q2Q % growth | -0.06 14.29% | -0.05 | -0.01 | -17.65% |
| Q4 2023 Q2Q % growth | -0.04 33.33% | -0.08 | 0.04 | 50.98% |
| Q3 2023 Q2Q % growth | -0.01 85.71% | -0.08 | 0.07 | 87.75% |
| Q2 2023 Q2Q % growth | -0.06 25.00% | -0.07 | 0.01 | 15.97% |
| Q1 2023 Q2Q % growth | -0.07 23.75% | -0.07 | 0.00 | 1.96% |
| Q4 2022 Q2Q % growth | -0.06 -50.00% | -0.09 | 0.03 | 30.80% |
| Q3 2022 Q2Q % growth | -0.07 | -0.09 | 0.02 | 23.75% |
| Q2 2022 Q2Q % growth | -0.08 11.11% | -0.09 | 0.01 | 9.51% |
| Q4 2021 Q2Q % growth | -0.04 29.82% | -0.10 | 0.06 | 57.98% |
| Q3 2021 Q2Q % growth | -0.07 12.50% | -0.09 | 0.02 | 23.75% |
| Q2 2021 Q2Q % growth | -0.09 10.00% | -0.09 | 0.00 | -1.81% |
| Q1 2021 Q2Q % growth | 0.00 100.00% | -0.08 | 0.08 | 100.00% |
| Q4 2020 Q2Q % growth | -0.06 -14.00% | -0.09 | 0.03 | 37.91% |
| Q3 2020 Q2Q % growth | -0.08 -60.00% | -0.12 | 0.04 | 34.64% |
| Q2 2020 Q2Q % growth | -0.10 -11.11% | -0.10 | 0.00 | 1.96% |
| Q1 2020 Q2Q % growth | -0.06 45.45% | -0.08 | 0.02 | 26.47% |
| Q4 2019 Q2Q % growth | -0.05 | -0.08 | 0.03 | 38.73% |
| Q3 2019 Q2Q % growth | -0.05 | -0.15 | 0.10 | 67.32% |
| Q2 2019 Q2Q % growth | -0.09 | -0.12 | 0.03 | 26.47% |
| Q1 2019 Q2Q % growth | -0.11 | -0.11 | 0.00 | -2.71% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | % | ||
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 20% |
| Revenue | N/A | N/A | N/A | N/A |